Blockbusters – drugs with annual sales of at least $1 billion – are to pharma companies what unicorns are to venture capitalists (VCs). They’re what you ultimately want to find. Proteins are the basis for many blockbuster therapeutics. For example, Insulin, the protein-based hormone used to treat diabetes, had a market value of $21.2 billion […]
We recently profiled eight companies creating exotic lab-based foods. Dubbed cellular agriculture, the technology to grow meat from animal cells has advanced swiftly in just a few years. One of the first commercial products just hit the menu at a Singaporean restaurant. At $23 for four chicken nuggets, it’s still more of a novelty than […]
In our recent article on DNA nanotechnology, we looked at a paper co-authored by George Church that refers to the “staggering” progress being made in gene editing. While it used to be that gene editing seemed to be synonymous with the acronym CRISPR, that’s not the case. CRISPR is just one of many methods one can use […]
As famous philosopher George Carlin used to remark, “Think about how stupid the average person is, and then realize that half of ’em are stupider than that.” One reason for the prevalence of stupidity is that mainstream conversation topics don’t revolve around anything intelligent, so we should hardly be surprised when only the nerdy kids are […]
We cover a ton of disruptive technologies here at Nanalyze so that our readers understand what’s out there that may be worth investing in as opportunities present themselves. The hope is that we learn something cool and make a few bucks in the process. It also doesn’t hurt that much of the emerging tech may […]
If you had to come up with a short list for the greatest advancements in technology that have been made in the last decade, you’d be hard pressed to place anything in front of the progress we’ve made in the world of genetics. For most of us, it’s been decades years since we took Biology 101 […]